JAK2 and hematopoietic and lymphoid cell neoplasm: Janus kinase 2 (JAK2) is a pivotal kinase in hematopoietic stem and progenitor cells (HSPCs), and its uncontrolled hyperactivation is a prominent oncogenic driver of hematopoietic neoplasms (17).